SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
PUMA BIOTECHNOLOGY, INC.
@PBYI_InsiderForm 4 Filing: AUERBACH ALAN H Sells $364,051.254 of $PBYI
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
PUMA BIOTECHNOLOGY, INC.
Ticker: $PBYI
Transaction Value
$364,051.254
Price/Share: $8.26
transaction date
2026-07-06
Shares: 44,058
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, AUERBACH ALAN H, holds the title of President and CEO at PUMA BIOTECHNOLOGY, INC..
On 2026-07-06, the insider transacted 44,058 shares.The shares were transacted at a weighted average price of $8.26 per share, resulting in a total market-relevant value of $364,051.254.
Executive Summary Summary
AUERBACH ALAN H (President and CEO) sold $364K of $PBYI
Post-Transaction Position: 7,261,671 shares
SEC Accession No: 0001437749-26-023079 (CIK: 1358285)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.